BROOKE EMFINGER: Open Payments
NPI 1275152647 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$218 in 8 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $218
Food & beverage: $218
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $123 |
| Janssen Biotech, Inc. | 1 | $30 |
| Arcutis Biotherapeutics, Inc. | 1 | $24 |
| Incyte Corporation | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: DUPIXENT, TREMFYA, Zoryve, OPZELURA, BRIDION.
Industry payments across LA — which companies pay providers there.
